Chemotherapy Induced Thrombocytopenia In Adult Subjects With Non Small Cell Lung Cancer Nsclc Ovarian Cancer Or Breast Cancer clinical trials

Explore recruiting chemotherapy induced thrombocytopenia in adult subjects with non small cell lung cancer nsclc ovarian cancer or breast cancer clinical trials.

Also recruiting in Europe

Chemotherapy Induced Thrombocytopenia In Adult Subjects With Non Small Cell Lung Cancer Nsclc Ovarian Cancer Or Breast Cancer trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

PROCLAIM: A Phase 3 Randomized Placebo-controlled Double-blind Study of Romiplostim for the Treatment of Chemotherapy-induced Thrombocytopenia in Patients Receiving Chemotherapy for Treatment of Non-small Cell Lung Cancer (NSCLC), Ovarian Cancer, or Breast Cancer

Greece, Portugal, Romania, Poland, Spain

Therapeutic confirmatory (Phase III) EU CTIS Study details

Chemotherapy Induced Thrombocytopenia In Adult Subjects With Non Small Cell Lung Cancer Nsclc Ovarian Cancer Or Breast Cancer trials by city

Chemotherapy Induced Thrombocytopenia In Adult Subjects With Non Small Cell Lung Cancer Nsclc Ovarian Cancer Or Breast Cancer in Toronto Chemotherapy Induced Thrombocytopenia In Adult Subjects With Non Small Cell Lung Cancer Nsclc Ovarian Cancer Or Breast Cancer in Vancouver Chemotherapy Induced Thrombocytopenia In Adult Subjects With Non Small Cell Lung Cancer Nsclc Ovarian Cancer Or Breast Cancer in Montreal Chemotherapy Induced Thrombocytopenia In Adult Subjects With Non Small Cell Lung Cancer Nsclc Ovarian Cancer Or Breast Cancer in Calgary Chemotherapy Induced Thrombocytopenia In Adult Subjects With Non Small Cell Lung Cancer Nsclc Ovarian Cancer Or Breast Cancer in Edmonton Chemotherapy Induced Thrombocytopenia In Adult Subjects With Non Small Cell Lung Cancer Nsclc Ovarian Cancer Or Breast Cancer in Ottawa Chemotherapy Induced Thrombocytopenia In Adult Subjects With Non Small Cell Lung Cancer Nsclc Ovarian Cancer Or Breast Cancer in Winnipeg Chemotherapy Induced Thrombocytopenia In Adult Subjects With Non Small Cell Lung Cancer Nsclc Ovarian Cancer Or Breast Cancer in Quebec City Chemotherapy Induced Thrombocytopenia In Adult Subjects With Non Small Cell Lung Cancer Nsclc Ovarian Cancer Or Breast Cancer in Hamilton Chemotherapy Induced Thrombocytopenia In Adult Subjects With Non Small Cell Lung Cancer Nsclc Ovarian Cancer Or Breast Cancer in Kitchener Chemotherapy Induced Thrombocytopenia In Adult Subjects With Non Small Cell Lung Cancer Nsclc Ovarian Cancer Or Breast Cancer in London Chemotherapy Induced Thrombocytopenia In Adult Subjects With Non Small Cell Lung Cancer Nsclc Ovarian Cancer Or Breast Cancer in Halifax Chemotherapy Induced Thrombocytopenia In Adult Subjects With Non Small Cell Lung Cancer Nsclc Ovarian Cancer Or Breast Cancer in New York Chemotherapy Induced Thrombocytopenia In Adult Subjects With Non Small Cell Lung Cancer Nsclc Ovarian Cancer Or Breast Cancer in Los Angeles Chemotherapy Induced Thrombocytopenia In Adult Subjects With Non Small Cell Lung Cancer Nsclc Ovarian Cancer Or Breast Cancer in Chicago Chemotherapy Induced Thrombocytopenia In Adult Subjects With Non Small Cell Lung Cancer Nsclc Ovarian Cancer Or Breast Cancer in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease